publicações selecionadas Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches Is Riparin III a promising drug in the treatment for depression?
